The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
DNA damage and senescence in the aging and Alzheimer’s disease cortex are not uniformly distributed
Open accessPreprint — published as 10.3390/biomedicines12061327 · Paper page
Abstract
Alzheimer’s disease (AD) is a neurodegenerative illness with a typical age of onset exceeding 65 years of age. The age-dependency of the condition led us to track the appearance of DNA damage in the frontal cortex of individuals who died with a diagnosis of AD. The focus on DNA damage was motivated by evidence that increasing levels of irreparable DNA damage are a major driver of the aging process. The connection between aging and the loss of genomic integrity is compelling because DNA damage has also been identified as a possible cause of cellular senescence. The number of senescent cells has been reported to increase with age, and their senescence-associated secreted products are likely contributing factors to age-related illnesses. We tracked DNA damage with 53BP1 and cellular senescence with p16 immunostaining of human post-mortem brain samples. We found that DNA damage is significantly increased in the BA9 region of the AD cortex when compared to the same region of unaXected controls (UC). In the AD but not UC cases, the density of cells with DNA damage increased with distance from the pia mater up to approximately layer V then decreased in deeper areas. This pattern of DNA damage was overlaid with the pattern of cellular senescence, which also increased with cortical depth. On a cell-by-cell basis, we found that the intensity of the two markers was tightly linked in the AD, but not the UC brain. To test whether DNA damage was a causal factor in the emergence of the senescence program, we used etoposide treatment to damage the DNA of cultured mouse primary neurons. While DNA damage increased after treatment, after 24 hours no change in the expression of senescence-associated markers was observed. Our work suggests that DNA damage and cellular senescence are both increased in the AD brain and increasingly coupled. We propose that in vivo the relationship between the two age-related processes is more complex than previously thought.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2023 Alzheimer's disease facts and figures
(2023) · Alzheimer's & Dementia · doi:10.1002/alz.13016 · Cited by 3,212
The central role of DNA damage in the ageing process
Schumacher, B., Pothof, J., Vijg, J., & Hoeijmakers, J. H. J. (2021) · Nature · doi:10.1038/s41586-021-03307-7 · Cited by 907
Flagged first, then by citations
Research works printed but not linked: 38
- 10.3389/fendo.2015.00013 · DOI
- 10.1101/cshperspect.a025130 · DOI
- 10.1038/s43587-021-00098-4 · DOI · Paper page
- 10.1016/j.mad.2008.03.008 · DOI
- 10.1016/j.mad.2016.05.006 · DOI · Paper page
- 10.1038/nature19329 · DOI · Paper page
- 10.1038/nrn4020 · DOI · Paper page
- 10.1016/j.tins.2023.11.003 · DOI
- 10.1126/science.aao4426 · DOI · Paper page
- 10.1038/nature02661 · DOI · Paper page
- 10.1038/s41588-022-01279-6 · DOI
- 10.1016/j.ajhg.2019.06.005 · DOI · Paper page
- 10.1016/j.cell.2005.01.028 · DOI · Paper page
- 10.1016/0197-4580(90)90542-8 · DOI · Paper page
- 10.1016/S0006-8993(97)81703-9 · DOI
- 10.3390/ijms22136748 · DOI · Paper page
- 10.1038/s41467-020-16361-y · DOI · Paper page
- 10.1186/s40478-019-0723-5 · DOI · Paper page
- 10.1016/j.mad.2016.04.005 · DOI · Paper page
- 10.1016/j.cell.2023.08.039 · DOI · Paper page
- 10.1038/362709a0 · DOI · Paper page
- 10.1038/nn.3356 · DOI · Paper page
- 10.1016/j.cell.2015.05.032 · DOI · Paper page
- 10.1073/pnas.0708043104 · DOI · Paper page
- 10.1523/ENEURO.0124-15.2016 · DOI
- 10.1038/nrc2440 · DOI · Paper page
- 10.1146/annurev-physiol-030212-183653 · DOI · Paper page
- 10.1038/s41598-017-17204-5 · DOI · Paper page
- 10.1016/j.dnarep.2024.103678 · DOI
- 10.1038/s41586-022-04640-1 · DOI · Paper page
- 10.3389/fneur.2024.1277613 · DOI
- 10.1001/archneurol.2009.15 · DOI · Paper page
- 10.1016/S0306-4522(02)00942-9 · DOI · Paper page
- 10.1016/S0306-4522(02)00056-8 · DOI
- 10.1523/JNEUROSCI.0172-22.2023 · DOI
- 10.1097/00001756-199611250-00050 · DOI · Paper page
- 10.1007/s007020050104 · DOI · Paper page
- 1997, Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer’s disease, Am J Pathol, 150, 1933
Metadata
- Authors
- Gutta, G., Mehta, J., Kingston, R., Xie, J., Brenner, E., Ma, F., & Herrup, K.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Ma, Fulin
- Venue
- Biomedicines
- Publisher
- openRxiv
- Published
- 2024-04-30
- Volume
- 12
- Issue
- 6
- Pages
- 1327-1327
- ISSN
- 2227-9059 (ISSN-L)
- PMC
- PMC11201767
- OpenAlex
- W4399670596
- Cited by
- 6
- References
- 2
- Citations by year
- 2026: 2 · 2025: 4
- FWCI
- 1.71
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Biomedicines (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Rare & Special e-Zone (The Hong Kong University of Science and Technology) (submittedVersion)
- Funders
- National Institutes of Health (4100087331)
- National Institute of Neurological Disorders and Stroke (RF1NS120922, R01NS120922)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- Alzheimer's disease, DNA damage, cellular senescence, brain aging, frontal cortex, 53BP1, p16, cortical depth, postmortem brain, etoposide, senescence-associated secretory phenotype, neuronal senescence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review